Publications:41
Video Visit Available
Accepting New Patients
- Mount Sinai Doctors
- Treats Adults
- Video Visit Available
- Accepting New Patients
Winona Tse, MD
Neurology
About Me
Dr. Tse earned a Bachelor of Arts degree in Biology from the Brown University Program in Liberal Medical Education in 1991, and then graduated with an M.D. degree from SUNY Stony Brook Medical School in 1995. Dr. Tse completed a neurology residency at Mount Sinai Medical Center in 1999, and in the final year served as a Chief Resident. She completed a fellowship in electromyography at the New York-Cornell Presbyterian Medical Center. She worked at Maimonides Hospital in Brooklyn from 2000 to 2002, where she saw a variety of movement disorders.
As an Professor of Neurology in the Mount Sinai Movement Disorders Center, Dr. Tse sees patients with Parkinson's disease, tremor disorders, restless legs syndrome, dystonia and other movement disorders. She has published several research articles and chapters in research journals and textbooks on the topics of Parkinson’s disease, essential tremor, restless legs syndrome and movement disorders in HIV infection. She sees patients with Parkinson’s disease and other movement disorders, performs botulinum toxin injections for a wide variety of neurologic conditions and runs clinical research trials in Parkinson disease (PD), deep brain stimulation in PD, botulinum toxin and cervical dystonia.
Dr. Tse is a diplomate of the American Board of Psychiatry and Neurology, and a diplomate of the American Academy of Electrodiagnostic Medicine.
Dr. Tse and her research team are committed to providing our patients with access to research studies that may lead to new breakthroughs in movement disorders research and treatment. Please see below for her current active research studies. For more information, please contact our research coordinators, Nina Buettner and Nenad Stojilkovic, at phone 212 241 5329. Or, email them at nina.buettner@mssm.edu and nenad.stojiljkovic@mssm.edu.
Dr. Tse offers telemedicine appointments when appropriate. Please call her office to schedule a video visit.
The state of Florida requires out-of-state professionals who are registered to provide telehealth services to display a hyperlink to the Florida Department of Health telehealth web page. This allows Florida patients who are receiving medical care by telehealth to confirm the provider’s licensure and Florida registration.
Language
English, Chinese (Cantonese), Spanish
Position
PROFESSOR | Neurology
Hospital Affiliations
- Mount Sinai Morningside
- Mount Sinai Beth Israel
- Mount Sinai Brooklyn
- Mount Sinai Queens
- The Mount Sinai Hospital
- Mount Sinai West
Research Topics
Neurology, Neuromodulation, Parkinson's Disease
Clinical Focus
- Ataxia
- Benign Essential Tremor
- Botulinum Toxin Injections
- Cervical Dystonia
- Chorea
- Deep Brain Stimulation (DBS)
- Dystonia
- Hemifacial Spasm
- Impaired Gait
- Lewy Body Disease
- Multiple System Atrophy
- Myoclonus
- Parkinson's Disease
- Restless Legs Syndrome
- Spasticity
- Tardive Dyskinesia
- Tremor
- Writers' Cramp
Education
MD, State University of NY at Stony Brook School of Medicine
Internship, Internal Medicine
Mount Sinai Hospital
Residency, Neurology
Mount Sinai Hospital
Fellowship, Neuromuscular Medicine
Cornell University Medical College
Certifications
Am Board of Electrodiagnostic Medicine
American Board of Psychiatry and Neurology
Research
Our research team includes:
Mindy Lopez, CCRC, ACRP-PM, Clinical Research Manager
Joan Bratton, BA, Clinical Research Associate
Christina Rosario, BA, Clinical Research Coordinator II
• A Phase 3, Twelve-week, Multi-Center, Multinational, Randomized, Double-Blind, Double-Dummy, Parallel Group Study to Determine the Efficacy, Safety and Tolerability of P2B001 Once Daily Compared to its Individual Components in Subjects With Early Parkinson’s Disease and to a Calibration Arm of Pramipexole ER.
• An Open-Label, Phase 3 Study Examining the Long-Term Safety, Tolerability and Efficacy of APL-130277 in Levodopa Responsive Patients with Parkinson’s Disease Complicated by Motor Fluctuations ("OFF" Episodes)
• A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Multi-Center Trial to Evaluate the Efficacy and Safety of a Single Treatment of DaxibotulinumtoxinA for Injection in Adults with Isolated Cervical Dystonia (ASPEN-1)
• A Phase 3, Open-Label, Multi-Center Trial to Evaluate the Long-Term Safety and Efficacy of Repeat Treatments of DaxibotulinumtoxinA for Injection in Adults with Isolated Cervical Dystonia (ASPEN-OLS)
• RESTORE: A clinical study of patients with symptomatic neuRogenic orthostatic hypotEnsion to assess Sustained effecTs Of dRoxidopa thErapy
• A Randomized, Parallel-group, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of SEP-363856 in Subjects with Parkinson’s Disease Psychosis
• A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Intravenously Administered BIIB092 in Participants with Progressive Supranuclear Palsy
• PL101-LID201 - A 14 week, double-blind, randomized three arm, parallel group study to assess the efficacy and safety of two doses of pridopidine versus placebo for the treatment of levodopa induced dyskinesias in Patients with Parkinson’s disease.
Insurance Information
Accepted insurance may vary by the doctor’s office location. Please contact the office directly to obtain the most up-to-date insurance information. Patients with Anthem Blue Cross Blue Shield (formerly known as Empire) or Molina insurance: please visit the linked pages in this message before booking to find out if out-of-network costs may apply to your next visit.
- 1199 SEIU
- AETNA - Commercial
- AETNA - Medicare
- CIGNA Healthcare
- Centivo
- EmblemHealth - GHI-PPO
- EmblemHealth - HIP
- EmblemHealth - HIP-Medicaid
- EmblemHealth - HIP-Medicare
- Empire Blue Cross Blue Shield - Commercial/Exchange
- Empire Blue Cross Blue Shield - HealthPlus Medicaid
- Empire Blue Cross Blue Shield - Medicare
- Fidelis Health Care
- HealthFirst Medicaid
- HealthFirst Medicare
- Horizon NJ
- Magnacare-Health Care
- Medicare - NJ
- Medicare - NY
- Metroplus
- Multiplan PHCS
- NJ Medicaid
- NY Medicaid
- Oscar
- Oxford - Freedom and Liberty
- Partners Health Plan
- United Health Care - Commercial
- United Health Care - Empire Plan
- United Health Care - Oxford Care
- United Health Care - Top Tier
- VNSNY Choice Medicare
- VillageCareMax
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.
Publications
Selected Publications
- Brain Atrophy Does Not Predict Clinical Progression in Progressive Supranuclear Palsy. Andrea Quattrone, Nicolai Franzmeier, Hans Jürgen Huppertz, Nicholas Seneca, Gabor C. Petzold, Annika Spottke, Johannes Levin, Johannes Prudlo, Emrah Düzel, Ikuko Aiba, Angelo Antonini, Diana Apetauerova, Jean Philippe Azulay, Ernest Balaguer Martinez, Jee Bang, Paolo Barone, Matthew Barrett, Danny Bega, Daniela Berg, Koldo Berganzo Corrales, Yvette Bordelon, Adam L. Boxer, Moritz Brandt, Norbert Brueggemann, Giovanni Castelnovo, Roberto Ceravolo, Rosalind Chuang, Sun Ju Chung, Alistair Church, Jean Christophe Corvol, Paola Cudia, Marian Dale, Luc Defebvre, Sophie Drapier, Erika D. Driver-Dunckley, Georg Ebersbach, Karla M. Eggert, Aaron Ellenbogen, Alexandre Eusebio, Andrew H. Evans, Natalia Fedorova, Elizabeth Finger, Alexandra Foubert-Samier, Boyd Ghosh, Lawrence Golbe, Francisco Grandas Perez, Murray Grossman, Deborah Hall, Kyoko Hamada, Winona Tse. Movement Disorders
- ENLITE PD: A Randomized Clinical Trial of Light Therapy for Impaired Sleep in Parkinson's Disease. Aleksandar Videnovic, Christopher S. Coffey, Elizabeth B. Klerman, Merit Cudkowicz, Hyun Joo Cho, Amy Amara, Karen Marder, Phyllis Zee, Christina Desir, Holly Ernst, Erin Steinhart, Michelle Costigan, Anna Gudjonsdottir, Elizabeth Klingner, Dixie Ecklund, Marianne Chase, Amy Wang, David Charles, David Clifford, Juliana Coleman, Alberto J. Espay, Albert Y. Hung, Srinath Kadimi, Annie Killoran, Lan Luo, Roneil Malkani, Jason Margolesky, Jennifer Marsella, Carine Maurer, Dragos Mihaila, Paolo Moretti, Ariane Park, Nicolas Phielipp, Harini Sarva, Binit Shah, Holly A. Shill, Andrew Siderowf, Valerie Suski, Jessica Tate, Winona Tse, Kara Wyant, Lin Zhang, Christine Annis, Katherine Ambrogi, Gabrielle Auerbach, Melanie Benge, Emma Blystone, Loraine Brenner, Carolina Burgos Aguilar, Grace Bwala. Movement Disorders
- Real-World Analysis of Healthcare Utilization, Treatment Patterns, and Economic Burden in Medicare Beneficiaries with Parkinson’s Disease: Implications by Levodopa Formulation and Disease Severity. Renée J.G. Arnold, Winona Tse, Kimberly Martin, Renee Kuan. PharmacoEconomics - Open
Patient Experience Star Ratings and Comments
The Patient Experience Star Rating reflects our patients’ perception of how well their Mount Sinai provider communicated with them during an office visit. The Star Rating is based on patient responses to three questions on a patient experience survey, a standardized questionnaire sent to verified patients and distributed by a third party vendor, Press Ganey. Responses are measured on a scale of 1 to 5, with 5 being the best score.
Care Provider’s Explanation
4.9 out of 5
Care Provider’s Concern
4.9 out of 5
Likelihood to Recommend Care Provider
4.8 out of 5
Industry Relationships
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.
Dr. Tse has not yet completed reporting of Industry relationships.
Mount Sinai’s faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.